Researchers from Purdue University have advanced a fundamentally new approach to brain interfaces: rather than implanting pre-made electrodes, they are creating conductive structures directly inside the brain through biochemical processes. The method is based on the concept of “growing” a soft electrode network, bypassing traditional rigid implants.
This technology functions like an on-site bio-factory. Following the injection of a chemical precursor into brain tissue, blood proteins, including hemoglobin, initiate a reaction that results in the formation of a pliable, flexible conductive network surrounding the neurons. This resulting structure precisely mirrors the tissue’s shape and moves in tandem with it.
The primary distinction of this new method is the capability for external modulation of brain activity using near-infrared light. Light pulses interact with the established network and can temporarily suppress neuronal activity, effectively “tuning” the function of specific brain regions without direct electrical stimulation.
The study’s author, Krishna Jayant, states that the “goal of the technology is to develop interfaces that are grown internally using the body’s own biochemical resources and can be controlled remotely, without wires or major surgery.”
Current neuro-implants are already employed to restore speech and movement in paralyzed patients, as well as treat severe forms of depression. Nevertheless, these rely on stiff microchips, necessitating complex surgeries and carrying the risk of damaging delicate brain tissue, leading to inflammation, scarring, and signal degradation.
The inherent mismatch between “rigid electronics” and the “soft brain” remains a central challenge in neuro-engineering. Even when successfully implanted, such devices often diminish in effectiveness over time or require replacement, increasing the hazards associated with repeated operations.
This novel methodology belongs to the growing field of soft bio-electronics. Previous experimental solutions in this area have included silk-like meshes overlaying the brain’s surface or micro-devices capable of penetrating tissue using immune cells. However, most of these systems remain external or are comprised of pre-fabricated components.
Certain prior research attempts aimed to assemble conductive materials within living tissues but encountered limitations: they either required toxic catalysts or systems that could only read signals, lacking the ability to influence them. The Purdue team has proposed an alternative: utilizing the body’s inherent biochemistry as the catalyst. According to study co-author Sanket Samal, “the core idea is to let the body perform the complex chemical labor itself.”
Experiments demonstrated that the conductive structure formation reaction is successful not only in living tissue but also in model systems. For instance, introducing the material into samples resulted in network formation over 24 hours at body temperature. In trials on zebrafish embryos, the majority of organisms survived and developed normally, suggesting low acute toxicity.
In the next phase, the technique was tested on mice. Following a minimally invasive injection into the motor cortex, a conductive network formed that integrated with neuronal activity without any indications of inflammation or overheating.
Of particular interest were trials involving dendrites—the branching structures of neurons that participate in information processing. In this context, the dendrites themselves aided in the creation of the conductive network, thus allowing for direct influence over local neural activity.
Under the influence of near-infrared light, the activity in these areas was transiently reduced. In mice, this resulted in difficulty executing a previously learned task (pressing a lever); however, function returned once the light was switched off, indicating the reversibility of the effect and preservation of memory.
A significant finding was the absence of infection signs, overheating, or pronounced immune response throughout the experimental series. This is particularly crucial for any technology operating within the central nervous system.
Potential applications include treating conditions characterized by hyperactivity in neural circuits, such as epilepsy and Parkinson’s disease, which currently rely on pharmaceuticals or invasive brain stimulators. However, the scientists stress that the technology is still in its nascent stage. The long-term persistence and safety profile of these structures within the body remain unknown.
Looking ahead, the method could potentially be extended beyond the brain—for example, to manage signaling in the spinal cord or cardiac tissue. The possibility of incorporating other functional materials, including magnetic components for enhanced activity control, is also being discussed. The ultimate vision is to create interfaces that do not merely interact with the brain but become an intrinsic, stable part of it over extended periods.
About the Author
